Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate

Conditions:   Type 2 Diabetes;   Cardiovascular Diseases;   Pharmacogenomic Drug Interaction Interventions:   Drug: Fenofibrate 145 mg;   Drug: Placebo Sponsor:   Mario Luca Morieri Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials